Highlights 2020 on anti-IL5 and other biologics,asthma and the pandemic

Prof. dr. Guy Brusselle

Guy Brusselle is head of the laboratory for translational research of obstructive pulmonary diseases at Ghent University. From September 2012 to October 2015, he served the European Respiratory Society (ERS) as Guidelines Director. Since September 2016, he has been appointed as the chair of the ERS Science Council.

Prof. dr. Parameswaran Nair

Professor Nair’s research focuses on developing and applying non-invasive measurements of airway inflammation in the treatment of asthma and COPD, particularly in patients with difficult-to-control and prednisone-dependent asthma. His laboratory characterizes the types of bronchitis in airway diseases using measurements in sputum, develops novel biomarkers in sputum, identifies mechanisms of bronchitis and explores novel targeted therapies of bronchitis. He directs the AllerGen National Centre of Excellence Clinical Investigators Consortium for Severe Asthma and is a co-investigator of the Canadian Respiratory Research Network.

At the Firestone Institute for Respiratory Health at St. Joseph’s Healthcare Hamilton, he looks after patients with complex obstructive airway diseases, severe asthma, recurrent bronchitis, and eosinophilic lung disorders. These unique multi-disciplinary clinics provide these patients access to biologics, molecular microbiology and bronchial thermoplasty and opportunities to participate in research programs.